cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rain Therapeutics Inc
4 own
4 watching
Current Price
$4.12
$0.3
(7.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
43.65M
52-Week High
52-Week High
5.62000
52-Week Low
52-Week Low
1.20000
Average Volume
Average Volume
0.01M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization43.65M
icon52-Week High5.62000
icon52-Week Low1.20000
iconAverage Volume0.01M
iconDividend Yield--
iconP/E Ratio--
What does the Rain Therapeutics Inc do?
Coliseum Acquisition Corp is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination, involving one or more businesses or assets. It intends to focus on sectors, including consumer product, service and media companies at the intersection of sports, entertainment, digital media and/or technology (Core Sectors). It has no operations and has generated no revenues.
Read More
How much money does Rain Therapeutics Inc make?
News & Events about Rain Therapeutics Inc.
PR Newswire
1 year ago
RAIN ALERT: The Law Offices of Vincent Wong Investigate Rain Oncology Inc. for Potential Violations of Securities Laws RAIN ALERT: The Law Offices of Vincent Wong Investigate Rain Oncology Inc. for Potential Violations of Securities Laws PR Newswire NEW YORK, July 3, 2023 NEW YORK, July 3, 2023...
PR Newswire
1 year ago
RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities Laws RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology...
PR Newswire
1 year ago
RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities Laws RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire NEW YORK, June...
Globe Newswire
1 year ago
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. (Rain or the Company) (NASDAQ: RAIN) concerning possible violations of federal securities laws. On or around April 22, 2021, Rain conducted its initial public ...
Globe Newswire
1 year ago
NEW YORK, June 17, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (Rain or the Company) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Frequently Asked Questions
Frequently Asked Questions
What is Rain Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Rain Therapeutics Inc shares?
plus_minus_icon
How can I buy Rain Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Rain Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rain Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Rain Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Rain Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rain Therapeutics Inc?
plus_minus_icon
What percentage is Rain Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rain Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.12
$0.3
(7.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00